Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium chloride + calcium chloride + sodium lactate + magnesium chloride + dextrose is a multi-electrolyte, dextrose-containing **peritoneal dialysis solution** used to manage renal failure during peritoneal dialysis. Dextrose creates an osmotic gradient across the peritoneal membrane, enabling ultrafiltration of excess water and removal of waste solutes; the electrolyte components support electrolyte balance, while lactate serves as a buffer that helps correct acid-base abnormalities. This composition is marketed in multiple product-specific formulations, including DIANEAL and DELFLEX products, with differing dextrose and calcium or magnesium concentrations. DIANEAL is indicated for acute or chronic renal failure, whereas DELFLEX is indicated for chronic kidney failure in patients maintained on peritoneal dialysis. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020183s024lbl.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + calcium chloride + sodium lactate + magnesium chloride + dextrose.